Neuroscience News

Wu Tsai Neuro and Knight Initiative for Brain Resilience affiliate, Michael Greicius, and others share their expertise on the limitations of the Alzheimer's drug Leqembi.

A little-understood part of the brain appears to be involved in starting seizures and keeping them going, according to Wu Tsai Neuro affiliate Ivan Soltesz and team.

Cases of patients who recovered from trauma after dreaming under surgical anesthesia spur Wu Tsai Neuro affiliate Boris Heifets and his team to investigate dreaming as therapy.

The recent discovery that intestinal neurons normally self-organize into a striped pattern around the time of birth could help explain wide-ranging GI disorders in children, say Wu Tsai Neuro Faculty Scholar Julia Kaltschmidt and her team.

Some of the 17 million Americans afflicted with major depressive disorder each year may soon receive a surprising new prescription from their clinician: Have fun on a virtual reality device.

Inside the brains of people with psychosis, two key systems are malfunctioning: a “filter” that directs attention toward important external events and internal thoughts, and a “predictor” composed of pathways that anticipate rewards.

Q&A with Wu Tsai Neuro affiliate Kathleen Poston about her work past and present on Parkinson’s disease. Poston studies the pathophysiology underlying the cognitive, behavioral and motor symptoms characteristic of Parkinson’s.

Wu Tsai Neuro affiliate and NeuroTech alum Lara Weed was always interested in how the world worked, and looking back now, she can see her interest in performance optimization developing over time.

A dedicated philanthropist and Stanford GSB alum, Knight has provided game-changing support for schools and initiatives across campus.

We all get moody -- it's part of human nature. But if you have people in your life afflicted with bipolar disorder, you quickly realize that not all moodiness is created equally.

Pro-inflammatory protein TREM1 in peripheral immune cells may promote age-related cognitive decline and dementia, according to Knight Initiative–funded research.

In this interview on the Huberman Lab podcast, Institute affiliate E.J. Chichilnisky discusses how studying the retina informs our understanding of the brain, the development of artificial retinas for treating incurable blindness, and his own personal journey.

This week, I join my producer Michael Osborne on his podcast, Famous and Gravy, to discuss the late, great neuroscientist and author Oliver Sacks.

A few closely related drugs, all squarely aimed at treating Alzheimer’s disease, have served up what can be charitably described as a lackadaisical performance. Wu Tsai Neuro and Knight Initiative affiliate Mike Greicius explains why.

This week, we sit down with neuroscientist Tony Wyss-Coray to learn about how some of your organs may be aging faster than the rest of you.

This week on From Our Neurons to Yours, we sit down with Stanford neurologist Kathleen Poston to learn about a sea change in our understanding of Parkinson's Disease.